• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.

作者信息

Wu Zhiyong, Hu Rui, Zhang Cuizhen, Ren Wei, Yu Anfeng, Zhou Xiaoyang

机构信息

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, Wuhan, 430060, China.

Department of Cardiology, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, Wuhan, 430060, China.

出版信息

Crit Care. 2020 Jun 5;24(1):290. doi: 10.1186/s13054-020-03015-0.

DOI:10.1186/s13054-020-03015-0
PMID:32503680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7273814/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a2b/7275563/490f1ef27b40/13054_2020_3015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a2b/7275563/490f1ef27b40/13054_2020_3015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a2b/7275563/490f1ef27b40/13054_2020_3015_Fig1_HTML.jpg

相似文献

1
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.血浆血管紧张素II水平升高是危重型新型冠状病毒肺炎患者的潜在发病机制。
Crit Care. 2020 Jun 5;24(1):290. doi: 10.1186/s13054-020-03015-0.
2
Using echocardiography to guide the treatment of novel coronavirus pneumonia.使用超声心动图指导新型冠状病毒肺炎的治疗。
Crit Care. 2020 Apr 10;24(1):143. doi: 10.1186/s13054-020-02856-z.
3
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
4
Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.内源性血管紧张素 II 中毒：COVID-19 假说。
Front Immunol. 2020 Jun 19;11:1472. doi: 10.3389/fimmu.2020.01472. eCollection 2020.
5
Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock.血管紧张素II用于治疗新型冠状病毒肺炎相关的血管扩张性休克
Anesth Analg. 2020 Jul;131(1):102-105. doi: 10.1213/ANE.0000000000004825.
6
Angiotensin II, III, and IV may be important in the progression of COVID-19.血管紧张素II、III和IV可能在2019冠状病毒病的进展中起重要作用。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972019. doi: 10.1177/1470320320972019.
7
First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia.台湾首例 COVID-19 死亡病例与流感阴性肺炎重症患者国家监测的细菌合并感染有关。
J Microbiol Immunol Infect. 2020 Aug;53(4):652-656. doi: 10.1016/j.jmii.2020.05.005. Epub 2020 May 20.
8
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?ACE2：理解 COVID-19 严重和危急情况病理生理学的关键分子：是魔鬼还是天使？
Viruses. 2020 Apr 28;12(5):491. doi: 10.3390/v12050491.
9
Critically-ill pediatric patients with COVID-19. An update.
Arch Argent Pediatr. 2020 Oct;118(5):e454-e462. doi: 10.5546/aap.2020.eng.e454.
10
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.为新冠肺炎重症患者做准备：体外膜肺氧合的潜在作用
JAMA. 2020 Apr 7;323(13):1245-1246. doi: 10.1001/jama.2020.2342.

引用本文的文献

1
Effect of Pituitary-Target Gland Axis on RAAS in the Context of COVID-19.在2019冠状病毒病背景下垂体-靶腺轴对肾素-血管紧张素-醛固酮系统的影响
Int J Med Sci. 2025 Jul 25;22(13):3439-3453. doi: 10.7150/ijms.114924. eCollection 2025.
2
Metabolomics and lipidomics of plasma biomarkers for tuberculosis diagnostics using UHPLC-HRMS.使用超高效液相色谱-高分辨率质谱法对用于结核病诊断的血浆生物标志物进行代谢组学和脂质组学研究。
Front Cell Infect Microbiol. 2025 Jun 30;15:1526740. doi: 10.3389/fcimb.2025.1526740. eCollection 2025.
3
Naturally Occurring Angiotensin Peptides Enhance the SARS-CoV-2 Spike Protein Binding to Its Receptors.

本文引用的文献

1
COVID-19 and the RAAS-a potential role for angiotensin II?新型冠状病毒肺炎与肾素-血管紧张素-醛固酮系统——血管紧张素II的潜在作用？
Crit Care. 2020 Apr 7;24(1):136. doi: 10.1186/s13054-020-02862-1.
2
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.新型冠状病毒受体识别：基于 SARS 冠状病毒长达十年结构研究的分析。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.
3
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
天然存在的血管紧张素肽增强严重急性呼吸综合征冠状病毒2刺突蛋白与其受体的结合。
Int J Mol Sci. 2025 Jun 24;26(13):6067. doi: 10.3390/ijms26136067.
4
The rationale of using angiotensin receptor blocker instead of pulmonary vasodilators to treat pulmonary hypertension in bronchopulmonary dysplasia: a case report and literature review.使用血管紧张素受体阻滞剂而非肺血管扩张剂治疗支气管肺发育不良相关性肺动脉高压的理论依据：1例病例报告及文献综述
Front Pediatr. 2025 May 19;13:1504180. doi: 10.3389/fped.2025.1504180. eCollection 2025.
5
COVID-19 and acute limb ischemia: latest hypotheses of pathophysiology and molecular mechanisms.2019冠状病毒病与急性肢体缺血：病理生理学和分子机制的最新假说
J Zhejiang Univ Sci B. 2025 Feb 19;26(4):333-352. doi: 10.1631/jzus.B2300512.
6
Bioinformatic characterization of ENPEP, the gene encoding a potential cofactor for SARS-CoV-2 infection.ENPEP的生物信息学特征，ENPEP是一种编码新型冠状病毒感染潜在辅助因子的基因。
PLoS One. 2024 Dec 11;19(12):e0307731. doi: 10.1371/journal.pone.0307731. eCollection 2024.
7
Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era.新型冠状病毒2型相关心肌纤维化的可能机制：大流行后时代的思考
Front Microbiol. 2024 Oct 8;15:1470953. doi: 10.3389/fmicb.2024.1470953. eCollection 2024.
8
The Renin-Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic.新型冠状病毒肺炎中的肾素-血管紧张素系统（RAS）：大流行开始三年后的现状
Microorganisms. 2024 Mar 14;12(3):583. doi: 10.3390/microorganisms12030583.
9
The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders.弗林蛋白酶在新冠病毒相关神经疾病发病机制中的作用。
Life (Basel). 2024 Feb 19;14(2):279. doi: 10.3390/life14020279.
10
The Role of the Kinin System and the Effect of Des-Arginine-Bradykinin on Coagulation and Platelet Function in Critically Ill COVID-19 Patients: A Secondary Analysis of a Prospective Observational Study.激肽系统的作用及去精氨酸-缓激肽对危重症 COVID-19 患者凝血和血小板功能的影响：一项前瞻性观察研究的二次分析。
Int J Mol Sci. 2024 Feb 16;25(4):2342. doi: 10.3390/ijms25042342.
一项重组人血管紧张素转换酶 2 在急性呼吸窘迫综合征中的临床试验。
Crit Care. 2017 Sep 7;21(1):234. doi: 10.1186/s13054-017-1823-x.
4
Interleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells.白细胞介素 22 通过抑制肺微血管内皮细胞凋亡减轻血管紧张素 II 诱导的急性肺损伤。
Sci Rep. 2017 May 19;7(1):2210. doi: 10.1038/s41598-017-02056-w.
5
VE-cadherin involved in the pulmonary microvascular endothelial cell barrier injury induced by angiotensin II through modulating the cellular apoptosis and skeletal rearrangement.血管内皮钙黏蛋白通过调节细胞凋亡和骨架重排参与血管紧张素II诱导的肺微血管内皮细胞屏障损伤。
Am J Transl Res. 2016 Oct 15;8(10):4310-4319. eCollection 2016.